ArticleBMC cancer2022

Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma.

Jingrui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.